Mechanism: Fasting upregulates H1.0, initiating an epigenetic reset that licenses AMPK-SIRT1-PGC-1α to simultaneously boost mitochondrial biogenesis and activate stringent mitophagy. Readout: Readout: This process purges damaged mtDNA, improving mitochondrial integrity and increasing the organism's lifespan.
Hypothesis
Intermittent and extended fasting create a somatic checkpoint that mimics germline quality control: the fasting‑induced linker histone H1.0 reprograms chromatin to a transiently pluripotent state, which licenses AMPK‑SIRT1‑PGC‑1α signaling to simultaneously boost mitochondrial biogenesis and activate a stringent mitophagy cascade. In this state, somatic cells—particularly tissue‑resident stem cells—subject mitochondria to a germline‑grade editing budget where organelles bearing mtDNA lesions are selectively eliminated via BNIP3/PINK1‑Parkin–dependent mitophagy, while healthy mitochondria are retained to repopulate the network. Consequently, fasting confers longevity benefits only when this mitochondrial purging succeeds; failure to remove damaged genomes abolishes the positive impact of reduced IGF‑1 signaling.
Mechanistic Reasoning
- Epigenetic gate: Fasting upregulates H1.0, which compacts chromatin and reduces transcriptional noise, creating a permissive environment for germline‑like regulatory networks (e.g., expression of piRNA pathway components) in somatic cells. This epigenetic resetting mirrors the genome‑wide reprogramming observed in primordial germ cells and may expose latent germline quality‑control factors.
- Coupled biogenesis‑mitophagy loop: AMPK activation raises NAD+, stimulating SIRT1 deacetylation of PGC‑1α, driving mitochondrial biogenesis. Simultaneously, AMPK phosphorylates ULK1 and activates BNIP3/PINK1, tagging nascent mitochondria for rapid turnover. The resulting flux generates a "turnover‑and‑selection" cycle akin to the germline bottleneck, where only mitochondria that pass functional assays (membrane potential, ROS handling) survive.
- Stem‑cell specificity: Tissue compartments with high stem‑cell activity (intestinal crypts, hematopoietic niche, muscle satellite cells) display elevated H1.0 induction and mitophagic flux during fasting, predicting stronger mtDNA genome purification in these locales.
- IGF‑1 dependence: Longevity gains from IGF‑1 reduction require mitochondrial genome stability; if mitophagy is impaired, mtDNA mutations accumulate, negating IGF‑1‑mediated benefits.
Testable Predictions
- H1.0 dependency: Knock‑down of H1.0 in mouse liver or intestinal epithelium will abolish fasting‑induced increases in BNIP3/PINK1 mitophagy markers and prevent improvement in mtDNA copy number integrity, despite intact AMPK‑SIRT1‑PGC‑1α activation.
- Stem‑cell‑restricted mtDNA purification: Lineage‑tracing of somatic stem cells undergoing 24‑h fasts will show a significant reduction in heteroplasmic mtDNA mutations compared with non‑stem counterparts; this effect will be lost in H1.0‑deficient stem cells.
- IGF‑1–mitophagy interaction: Mice with liver‑specific IGF‑1 receptor knockout will exhibit extended lifespan only when fasting‑induced mitophagy is functional; pharmacological inhibition of mitophagy (e.g., Mdivi‑1) will erase the lifespan extension.
- Cross‑tissue variability: Skeletal muscle from young humans undergoing a 48‑h fast will show no change in H1.0 levels or mitophagic flux, predicting absent mtDNA quality‑control benefits, consistent with prior negative biogenesis data.
Falsification
If fasting improves mitochondrial function and extends lifespan in H1.0‑deficient or mitophagy‑blocked models, the hypothesis that germline‑like selection via H1.0‑gated mitophagy underlies fasting’s benefits would be refuted. Similarly, if mtDNA mutation load fails to decline in fasting‑treated stem cells despite robust H1.0 induction and mitophagy activation, the proposed selective purging mechanism would be invalidated.
References
Comments
Sign in to comment.